The Cooper Companies, Inc. (NYSE:COO) Expected to Announce Earnings of $3.45 Per Share

Analysts expect The Cooper Companies, Inc. (NYSE:COO – Get Rating) to post earnings per share (EPS) of $3.45 for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Cooper Companies’ earnings. The lowest EPS estimate is $3.41 and the highest is $3.51. Cooper Companies posted earnings of $3.38 per share during the same quarter last year, which suggests a positive year over year growth rate of 2.1%. The business is expected to issue its next earnings report after the market closes on Monday, January 1st.

On average, analysts expect that Cooper Companies will report full year earnings of $14.09 per share for the current financial year, with EPS estimates ranging from $13.90 to $14.45. For the next fiscal year, analysts forecast that the firm will post earnings of $15.97 per share, with EPS estimates ranging from $15.50 to $16.39. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that follow Cooper Companies.

Cooper Companies (NYSE:COO – Get Rating) last posted its earnings results on Thursday, March 3rd. The medical device company reported $3.24 EPS for the quarter, topping analysts’ consensus estimates of $3.10 by $0.14. The business had revenue of $787.20 million for the quarter, compared to analysts’ expectations of $739.30 million. Cooper Companies had a return on equity of 9.89% and a net margin of 31.00%. The business’s revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.17 earnings per share.

A number of equities research analysts recently issued reports on COO shares. Wells Fargo & Company reduced their target price on Cooper Companies from $495.00 to $380.00 and set an “overweight” rating on the stock in a research note on Monday. Needham & Company LLC started coverage on Cooper Companies in a report on Friday, April 8th. They issued a “hold” rating for the company. Stephens boosted their price target on Cooper Companies from $430.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, March 7th. Piper Sandler boosted their price target on Cooper Companies from $490.00 to $500.00 in a report on Friday, March 4th. Finally, StockNews.com started coverage on Cooper Companies in a report on Thursday, March 31st. They issued a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Cooper Companies has a consensus rating of “Buy” and a consensus price target of $457.00.

In other Cooper Companies news, SVP Agostino Ricupati sold 5,607 shares of the company’s stock in a transaction dated Friday, March 18th. The shares were sold at an average price of $421.51, for a total value of $2,363,406.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jody S. Lindell sold 700 shares of the company’s stock in a transaction dated Monday, April 4th. The shares were sold at an average price of $421.04, for a total transaction of $294,728.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 19,646 shares of company stock valued at $8,195,614. 1.70% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of the business. Ellevest Inc. lifted its position in shares of Cooper Companies by 31.3% during the fourth quarter. Ellevest Inc. now owns 109 shares of the medical device company’s stock worth $46,000 after purchasing an additional 26 shares during the last quarter. MAI Capital Management lifted its position in shares of Cooper Companies by 0.9% during the fourth quarter. MAI Capital Management now owns 3,236 shares of the medical device company’s stock worth $1,356,000 after purchasing an additional 28 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Cooper Companies by 12.9% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 263 shares of the medical device company’s stock worth $110,000 after purchasing an additional 30 shares during the last quarter. Veritable L.P. lifted its position in shares of Cooper Companies by 3.4% during the first quarter. Veritable L.P. now owns 972 shares of the medical device company’s stock worth $406,000 after purchasing an additional 32 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its position in shares of Cooper Companies by 66.7% during the third quarter. O Shaughnessy Asset Management LLC now owns 85 shares of the medical device company’s stock worth $35,000 after purchasing an additional 34 shares during the last quarter. 98.38% of the stock is owned by institutional investors.

Shares of COO stock opened at $338.72 on Friday. The stock’s 50-day moving average price is $384.22 and its 200 day moving average price is $395.48. The stock has a market capitalization of $16.70 billion, a PE ratio of 17.97, a price-to-earnings-growth ratio of 2.19 and a beta of 0.90. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 0.34. Cooper Companies has a 52-week low of $309.43 and a 52-week high of $463.59.

Cooper Companies Company Profile (Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles